From: Immunohistochemical basigin expression level in thyroid cancer tissues
Category | Term | Count | % | P value |
---|---|---|---|---|
GO_BP | Extracellular matrix organization | 52 | 4 | 5.9E− 17 |
GO_BP | Cell adhesion | 81 | 6.2 | 1.4E− 14 |
GO_BP | Inflammatory response | 62 | 4.8 | 6E− 10 |
GO_BP | Signal transduction | 128 | 9.8 | 1.5E− 07 |
GO_BP | Collagen catabolic process | 19 | 1.5 | 2.2E− 07 |
GO_BP | Endothelial cell migration | 12 | 0.9 | 1.9E− 06 |
GO_BP | Positive regulation of synapse assembly | 17 | 1.3 | 3.5E− 06 |
GO_BP | Cellular response to tumor necrosis factor | 23 | 1.8 | 5.8E− 06 |
GO_BP | Response to drug | 44 | 3.4 | 6.9E− 06 |
GO_BP | Leukocyte migration | 24 | 1.8 | 0.00001 |
GO_BP | Positive regulation of apoptotic process | 43 | 3.3 | 0.000011 |
GO_BP | BMP signaling pathway | 18 | 1.4 | 0.000014 |
GO_BP | Vasculogenesis | 15 | 1.2 | 0.000021 |
GO_BP | Skeletal system development | 25 | 1.9 | 0.000024 |
GO_BP | Angiogenesis | 34 | 2.6 | 0.000031 |
GO_BP | Response to mechanical stimulus | 15 | 1.2 | 0.00004 |
GO_BP | Response to axon injury | 10 | 0.8 | 0.000055 |
GO_BP | Positive regulation of gene expression | 37 | 2.8 | 0.00007 |
GO_BP | SMAD protein signal transduction | 15 | 1.2 | 0.000072 |
GO_BP | Cell chemotaxis | 15 | 1.2 | 0.00012 |
GO_CC | Extracellular space | 199 | 15.3 | 1.9E− 26 |
GO_CC | Proteinaceous extracellular matrix | 70 | 5.4 | 1.3E− 22 |
GO_CC | Extracellular region | 208 | 16 | 2.4E− 20 |
GO_CC | Extracellular exosome | 311 | 23.9 | 6E− 20 |
GO_CC | Extracellular matrix | 62 | 4.8 | 4.5E− 15 |
GO_CC | Cell surface | 80 | 6.2 | 1E− 10 |
GO_CC | Collagen trimer | 26 | 2 | 1.5E− 09 |
GO_CC | Integral component of plasma membrane | 151 | 11.6 | 2.5E− 08 |
GO_CC | Plasma membrane | 361 | 27.8 | 4.4E− 08 |
GO_CC | Basement membrane | 20 | 1.5 | 1.1E− 06 |
GO_CC | Receptor complex | 24 | 1.8 | 0.000015 |
GO_CC | Perinuclear region of cytoplasm | 71 | 5.5 | 0.000023 |
GO_CC | Endoplasmic reticulum lumen | 29 | 2.2 | 0.00011 |
GO_CC | Dendritic spine | 19 | 1.5 | 0.00013 |
GO_CC | Z disk | 21 | 1.6 | 0.00014 |
GO_CC | Integral component of membrane | 409 | 31.5 | 0.0002 |
GO_CC | Anchored component of membrane | 20 | 1.5 | 0.00022 |
GO_CC | Focal adhesion | 46 | 3.5 | 0.00041 |
GO_CC | Endoplasmic reticulum | 82 | 6.3 | 0.00064 |
GO_CC | Cell | 17 | 1.3 | 0.0012 |
GO_MF | Calcium ion binding | 99 | 7.6 | 1.2E− 11 |
GO_MF | Heparin binding | 37 | 2.8 | 1E− 10 |
GO_MF | Extracellular matrix structural constituent | 20 | 1.5 | 5.3E− 08 |
GO_MF | Identical protein binding | 89 | 6.8 | 2.1E− 07 |
GO_MF | Integrin binding | 23 | 1.8 | 1.6E− 06 |
GO_MF | Protein homodimerization activity | 79 | 6.1 | 0.000035 |
GO_MF | Glycoprotein binding | 15 | 1.2 | 0.000089 |
GO_MF | SMAD binding | 12 | 0.9 | 0.000098 |
GO_MF | Extracellular matrix binding | 9 | 0.7 | 0.00022 |
GO_MF | Transforming growth factor beta binding | 7 | 0.5 | 0.00042 |
GO_MF | Calcium-dependent phospholipid binding | 13 | 1 | 0.00042 |
GO_MF | Collagen binding | 13 | 1 | 0.00058 |
GO_MF | Aldehyde dehydrogenase (NAD) activity | 7 | 0.5 | 0.00061 |
GO_MF | Receptor activity | 29 | 2.2 | 0.00073 |
GO_MF | Low-density lipoprotein receptor activity | 6 | 0.5 | 0.0011 |
GO_MF | Chemokine activity | 11 | 0.8 | 0.0014 |
GO_MF | Actin filament binding | 20 | 1.5 | 0.0014 |
GO_MF | Calcium-dependent protein binding | 12 | 0.9 | 0.0015 |
GO_MF | Structural constituent of muscle | 10 | 0.8 | 0.0017 |
GO_MF | Protein binding | 642 | 49.4 | 0.0018 |
KEGG_PATHWAY | ECM-receptor interaction | 25 | 1.9 | 1.3E− 08 |
KEGG_PATHWAY | Complement and coagulation cascades | 20 | 1.5 | 4.5E− 07 |
KEGG_PATHWAY | Staphylococcus aureus infection | 17 | 1.3 | 1.2E− 06 |
KEGG_PATHWAY | p53 signaling pathway | 18 | 1.4 | 6.2E− 06 |
KEGG_PATHWAY | Protein digestion and absorption | 20 | 1.5 | 0.000022 |
KEGG_PATHWAY | Malaria | 14 | 1.1 | 0.000046 |
KEGG_PATHWAY | Amoebiasis | 21 | 1.6 | 0.0001 |
KEGG_PATHWAY | Transcriptional misregulation in cancer | 28 | 2.2 | 0.00012 |
KEGG_PATHWAY | Phagosome | 26 | 2 | 0.00013 |
KEGG_PATHWAY | Focal adhesion | 32 | 2.5 | 0.00015 |
KEGG_PATHWAY | Pathways in cancer | 49 | 3.8 | 0.0005 |
KEGG_PATHWAY | Pertussis | 15 | 1.2 | 0.0012 |
KEGG_PATHWAY | Cytokine-cytokine receptor interaction | 33 | 2.5 | 0.0013 |
KEGG_PATHWAY | Thyroid hormone synthesis | 14 | 1.1 | 0.0019 |
KEGG_PATHWAY | Leukocyte transendothelial migration | 19 | 1.5 | 0.0023 |
KEGG_PATHWAY | Cell adhesion molecules (CAMs) | 21 | 1.6 | 0.0047 |
KEGG_PATHWAY | Mineral absorption | 10 | 0.8 | 0.0048 |
KEGG_PATHWAY | Leishmaniasis | 13 | 1 | 0.0063 |
KEGG_PATHWAY | PI3K-Akt signaling pathway | 40 | 3.1 | 0.0065 |
KEGG_PATHWAY | TGF-beta signaling pathway | 14 | 1.1 | 0.0097 |